Latest IPO in India: Positive Sacheerome Ltd SME IPO — 7 Key Details Revealed!
Sacheerome Ltd, founded in 1992 and based in New Delhi, is a B2B manufacturer of fragrances and flavours. It serves FMCG industries like personal care, food & beverages, fabric care, and exports to the Middle East and Africa. With two manufacturing units and strong R&D backing, the company holds certifications like IFRA, FSSAI, and ISO 9001:2015.
🗓 IPO Timeline & Details
- Bidding Dates: June 9–11, 2025
- Allotment Date: June 12
- Refund & Share Credit: June 13
- Listing Date: June 16, 2025 (NSE SME)
💸 Price Band & Lot Size
- Price Band: ₹96–₹102
- Lot Size: 1,200 shares (₹122,400 minimum investment)
📈 Issue Size & Use of Funds
The IPO aims to raise ₹61.62 crore via a fresh issue of 60.41 lakh equity shares. The company plans to use 92% of the proceeds for a new production and R&D facility in YEIDA, and the rest for general corporate purposes.
📊 Financial Overview
Sacheerome Ltd reported:
- FY23 Revenue: ₹70 crore → FY25 (est.): ₹108 crore
- FY23 PAT: ₹5.99 crore → FY25 (est.): ₹15.98 crore
- TTM ROCE: ~39%, ROE: ~30%
🌟 Strengths
- Strong in-house R&D and customization
- Certified compliance (FSSAI, ISO, IFRA)
- Consistent revenue and margin growth
⚠️ Risks
- High customer concentration risk
- Exposure to raw material price volatility
- Pending legal cases and SME liquidity risk
📊 IPO Anchor Investors & Promoter Holding
Category | Shares | % of Issue |
---|---|---|
Anchor Investors | 17,19,600 | 28.47% |
QIB | 11,47,200 | 18.99% |
Retail Investors | 20,10,000 | 33.27% |
NII | 8,61,600 | 14.26% |
Promoter (Post‑IPO) | — | 71.54% |
📈 Grey Market Premium (GMP)
Source / Platform | GMP (₹) | Implied Listing Price | Estimated Listing Gain |
---|---|---|---|
Chittorgarh / NDTV | ₹30 | ₹132 | ~29% |
Mint / InvestorGain | ₹21 | ₹123 | ~20.6% |
🔍 Final Thoughts
Sacheerome Ltd’s SME IPO appears promising with solid fundamentals, modern R&D, and a decent GMP trend. However, investors must weigh the SME liquidity risks and reliance on top clients. Overall, this IPO suits risk-tolerant investors looking to diversify with high-growth small-cap entries.